| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |